MENU
CTOR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Citius Oncology (CTOR) Earnings Date & Reports
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies... Show more
A.I. Advisor
published Earnings
CTOR is expected to report earnings to fall 100.00% to 0 cents per share on February 12
Q4'26
Est.
$0.00
Q2'26
Missed
by $0.08
Q4'25
Missed
by $0.04
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.01
The last earnings report on August 14 showed earnings per share of -7 cents, missing the estimate of 0 cents. With 31.83K shares outstanding, the current market capitalization sits at 53.88M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsGeneric
Industry
N/A
Address
11 Commerce Drive
Phone
+1 908 967-6677
Employees
N/A
Web
https://www.citiusonc.com